OmniAb Platform

OmniAb uses newly patented technology to deliver fully human OmniAb antibodies with high affinity, specificity, expression, solubility and stability. While transgenic mice expressing human antibodies date back to the 1990's, in recent years scientists from Ligand-acquired Open Monoclonal Technology and Crystal Bioscience were the first to create rats and chickens, respectively, expressing diversified repertoires of antibodies with fully human idiotypes. OmniMouse complements the genetically engineered rats and chickens to form the industry's only platform with three species.

OmniAb: Humanized Rodent and Chicken Platforms for Antibody Discovery